A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

Clinical Trial ID NCT01662531

Rank	Title	Journal	Year	PubWeight™‹?›
1	Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial.	Thromb Haemost	2016	0.76